These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7474003)

  • 1. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome.
    Ertel W; Keel M; Bonaccio M; Steckholzer U; Gallati H; Kenney JS; Trentz O
    J Trauma; 1995 Nov; 39(5):879-85; discussion 885-7. PubMed ID: 7474003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased plasma level of Type I (p55) and Type II (p75) TNF-receptors following trauma].
    Keel M; Bonaccio M; Steckholzer U; Ungethüm U; Gallati H; Trentz O; Ertel W
    Swiss Surg; 1995; (5):241-4. PubMed ID: 7584592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
    Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J
    Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma.
    Keel M; Ecknauer E; Stocker R; Ungethüm U; Steckholzer U; Kenney J; Gallati H; Trentz O; Ertel W
    J Trauma; 1996 Jun; 40(6):907-12; discussion 912-4. PubMed ID: 8656476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure.
    Partrick DA; Moore EE; Moore FA; Biffl WL; Barnett CC
    Am J Surg; 1999 Dec; 178(6):564-9. PubMed ID: 10670873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.
    Tillie-Leblond I; Pugin J; Marquette CH; Lamblin C; Saulnier F; Brichet A; Wallaert B; Tonnel AB; Gosset P
    Am J Respir Crit Care Med; 1999 Feb; 159(2):487-94. PubMed ID: 9927362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM; Puri P; Mealy K; Reen DJ
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma.
    Maier B; Lefering R; Lehnert M; Laurer HL; Steudel WI; Neugebauer EA; Marzi I
    Shock; 2007 Dec; 28(6):668-674. PubMed ID: 18092384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor.
    Karkar AM; Tam FW; Steinkasserer A; Kurrle R; Langner K; Scallon BJ; Meager A; Rees AJ
    Kidney Int; 1995 Dec; 48(6):1738-46. PubMed ID: 8587234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss.
    Rimaniol AC; Zylberberg H; Zavala F; Viard JP
    AIDS; 1996 Oct; 10(12):1349-56. PubMed ID: 8902063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
    Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
    Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
    J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.